We are live on ! Find out more
CD

Christopher Davis Davis Selected Advisers

AUM $23.3B
1-Year Est. Return 26.95%
 

Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.95%
3 Year Est. Return
+93.11%
5 Year Est. Return
+96.73%
10 Year Est. Return
+388.76%
AUM
$22.9B
AUM Growth
-$331M
Cap. Flow
-$1.06B
Cap. Flow %
-4.63%
Top 10 Hldgs %
47.88%
Holding
146
New
5
Increased
59
Reduced
74
Closed
4

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$550M
2
AMZN icon
Amazon
AMZN
+$169M
3
JPM icon
JPMorgan Chase
JPM
+$152M
4
V icon
Visa
V
+$95.4M
5
UNH icon
UnitedHealth
UNH
+$66.7M

Sector Composition

Rank Sector Weight
1 Financials 38.79%
2 Consumer Discretionary 13.4%
3 Communication Services 12.27%
4 Energy 10.41%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.06T
$284M 1.24%
1,677,917
+5,801
+0.3% +$965K
KMX icon
27
CarMax
KMX
$8.82B
$277M 1.21%
4,390,623
-247,128
-5% -$14.9M
MKL icon
28
Markel Group
MKL
$22.2B
$269M 1.18%
276,033
-5,152
-2% -$5M
COST icon
29
Costco
COST
$420B
$269M 1.18%
1,683,514
-84,153
-5% -$14.5M
ESRX
30
DELISTED
Express Scripts Holding Company
ESRX
$256M 1.12%
4,011,191
-246,073
-6% -$15.5M
MSFT icon
31
Microsoft
MSFT
$3.59T
$255M 1.11%
3,695,488
-252,253
-6% -$17.3M
L icon
32
Loews
L
$22.5B
$245M 1.07%
5,231,077
-243,286
-4% -$11.4M
AXTA icon
33
Axalta
AXTA
$7.75B
$232M 1.01%
7,228,390
+528,794
+8% +$16.9M
CB icon
34
Chubb
CB
$132B
$214M 0.94%
1,473,874
-88,367
-6% -$12.4M
ORCL icon
35
Oracle
ORCL
$422B
$202M 0.89%
4,034,353
-79,318
-2% -$3.61M
ECL icon
36
Ecolab
ECL
$78.9B
$185M 0.81%
1,396,786
-277,086
-17% -$35.8M
BKNG icon
37
Booking.com
BKNG
$158B
$170M 0.74%
2,273,475
-762,200
-25% -$55.9M
SFUN
38
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$101M 0.44%
544,790
+136,073
+33% +$23.5M
JD icon
39
JD.com
JD
$39.7B
$96.3M 0.42%
2,456,456
+132,295
+6% +$4.99M
USB icon
40
US Bancorp
USB
$96.7B
$70.1M 0.31%
1,351,009
-1,004,720
-43% -$51.7M
EDU icon
41
New Oriental
EDU
$8.88B
$66.5M 0.29%
943,253
+110,914
+13% +$7.62M
ZTO icon
42
ZTO Express
ZTO
$16.2B
$65.7M 0.29%
4,704,977
+517,045
+12% +$7.14M
BABA icon
43
Alibaba
BABA
$286B
$60.1M 0.26%
426,747
+22,477
+6% +$2.78M
EG icon
44
Everest Group
EG
$14.2B
$58.3M 0.26%
228,871
+511
+0.2% +$126K
ANGI icon
45
Angi Inc
ANGI
$200M
$57.9M 0.25%
452,459
+121,895
+37% +$12M
HOLI
46
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$56.3M 0.25%
3,391,934
+2,129,546
+169% +$34.7M
GS icon
47
Goldman Sachs
GS
$303B
$55.7M 0.24%
251,126
-164
-0.1% -$36.4K
QVCGA
48
DELISTED
QVC Group Inc Series A
QVCGA
$53.1M 0.23%
44,557
-3,817
-8% -$4.23M
TAL icon
49
TAL Education Group
TAL
$6.28B
$52.2M 0.23%
2,559,516
+260,364
+11% +$5.11M
MON
50
DELISTED
Monsanto Co
MON
$50.4M 0.22%
426,200
-4,713,180
-92% -$550M

Similar funds

Christopher Davis's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.

  • Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
  • Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
  • Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
  • Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
  • Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
  • Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
  • Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.

Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.